| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.8 |